I beg to differ guys.
I was invested with another biotech of similar size that let one of the big guys take over and run the ship so to speak and the end result was that the journey through the FDA mire was drawn out for five plus years and eventually through some very sly and calculated moves the big guys ended up with the intellectual property and the little biotech went bankrupt.
What I have observed so far in the Starpharma journey ( I have been in and out of Starpharma a couple of times in the last four years) is a company whose board and management seem to have good morals and ethics and who have done an incredible job to not only be as far as they are down the regulatory road but to be there with comparatively small share dilution and in a very good position financially.
For what it's worth my vote is to let Jackie and her crew steer the ship the way they see fit because up to this point they are doing an awesome job.
Cheers.
Add to My Watchlist
What is My Watchlist?
